MIRANDA BEVARD: Open Payments
NPI 1447852447 · SMITHFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,389 in 74 payments from 19 companies in 2025. Trend: 2023 $1,961 · 2024 $2,503 · 2025 $1,389
Food & beverage: $1,389
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $208 |
| Novo Nordisk Inc | 12 | $207 |
| AstraZeneca Pharmaceuticals LP | 4 | $189 |
| Lilly USA, LLC | 9 | $141 |
| PFIZER INC. | 6 | $110 |
| Janssen Pharmaceuticals, Inc | 4 | $89 |
| Daiichi Sankyo Inc. | 3 | $79 |
| Amgen Inc. | 4 | $78 |
| GlaxoSmithKline, LLC. | 4 | $62 |
| Phathom Pharmaceuticals, Inc. | 3 | $35 |
Products named: QULIPTA, AIRSUPRA, MOUNJARO, Wegovy, SPRAVATO, INJECTAFER, NURTEC ODT, EVENITY.
Industry payments across PA — which companies pay providers there.
